High-dose anakinra to treat refractory immune effector cell-associated neurotoxicity syndrome in CAR T-cell therapy recipientsEmily C. Liang, Richard T. Maziarz, Smith Kungwankiattichai et al.|Blood|2025Cited by 0
Independent assessment of ALC thresholds currently in use to predict motor/neurocognitive toxicities (MNTs) after treatment with ciltacabtagene autoleucelYein Jeon, Jordan Gauthier, Xiancheng Wu et al.|Blood|2025Cited by 0
Time-Series Clustering Captures Patterns of Early Immune Effector Cell–Associated Hematotoxicity That Are Predictable Using Tree-Based ModelsEmily C. Liang, Jordan Gauthier, Yein Jeon et al.|JCO Clinical Cancer Informatics|2026Cited by 0
NEMO: A Novel Prognostic Model of Non-Icans Neurotoxicities Associated with Ciltacabtagene AutoleucelYein Jeon, Jordan Gauthier, Danai Dima et al.|Transplantation and Cellular Therapy|2026Cited by 0
Early neurologic response predicts outcomes after anakinra for immune effector cell–associated neurotoxicity syndromeEmily C. Liang, Jordan Gauthier, Smith Kungwankiattichai et al.|Blood Advances|2026Cited by 0